Why the study?
Enteroviruses are primarily transmitted by the fecal-oral route, but the events associated with their intestinal replication in vivo are poorly defined.
Type I and III interferons have distinct, type-specific roles in controlling enterovirus replication in the GI tract and its dissemination.
Answers are grounded in this paper and cite their sources.
Neonatal mouse model defines type I/III IFN roles in enterovirus GI replication and spread; leaves open human translation and therapeutic targeting.
Enteroviruses are amongst the most common viral infectious agents of humans and cause a broad spectrum of mild-to-severe illness. Enteroviruses are primarily transmitted by the fecal-oral route, but the events associated with their intestinal replication in vivo are poorly defined. Here, we developed a neonatal mouse model of enterovirus infection by the enteral route using echovirus 5 and used this model to define the differential roles of type I and III interferons (IFNs) in enterovirus replication in the intestinal epithelium and subsequent dissemination to secondary tissues. We show that human FcRn, the primary receptor for echoviruses, is essential for intestinal infection by the enteral route and that type I IFNs control dissemination to secondary sites, including the liver. In contrast, type III IFNs limit enterovirus infection in the intestinal epithelium and mice lacking this pathway exhibit persistent epithelial replication. Finally, we show that echovirus infection in the small intestine is cell-type specific and occurs exclusively in enterocytes. These studies define the type-specific roles of IFNs in enterovirus infection of the GI tract and the cellular tropism of echovirus intestinal replication.
No takes yet. Share an insight, caveat, or question.
Wells et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: